Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami M Kabadi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
ACS Synthetic Biology|October 18, 2014
Special issue on engineered DNA-binding proteinsAmi M Kabadi, Charles A Gersbach
Methods (San Diego, Calif.)|July 11, 2014
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expressionAmi M Kabadi, Charles A Gersbach
Nucleic Acids Research|August 15, 2014
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M Kabadi, David G Ousterout, Isaac B Hilton, et al.
Stem Cell Reports|December 3, 2014
A CRISPR/Cas9-based system for reprogramming cell lineage specificationSyandan Chakraborty, HaYeun Ji, Ami M Kabadi, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and BDavid M Gooden, Dawn M Z Schmidt, Julie A Pollock, et al.
Nature Communications|February 19, 2015
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
ACS Synthetic Biology|December 11, 2014
Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domainAmi M Kabadi, Pratiksha I Thakore, Christopher M Vockley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2021
Epigenome editing of the CFTR-locus for treatment of cystic fibrosisAmi M Kabadi, Leah Machlin, Nikita Dalal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleasesDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
Nature Methods|October 27, 2015
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsPratiksha I Thakore, Anthony M D'Ippolito, Lingyun Song, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
ACS Synthetic Biology|October 18, 2014
Special issue on engineered DNA-binding proteinsAmi M Kabadi, Charles A Gersbach
Methods (San Diego, Calif.)|July 11, 2014
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expressionAmi M Kabadi, Charles A Gersbach
Nucleic Acids Research|August 15, 2014
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M Kabadi, David G Ousterout, Isaac B Hilton, et al.
Stem Cell Reports|December 3, 2014
A CRISPR/Cas9-based system for reprogramming cell lineage specificationSyandan Chakraborty, HaYeun Ji, Ami M Kabadi, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and BDavid M Gooden, Dawn M Z Schmidt, Julie A Pollock, et al.
Nature Communications|February 19, 2015
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
ACS Synthetic Biology|December 11, 2014
Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domainAmi M Kabadi, Pratiksha I Thakore, Christopher M Vockley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2021
Epigenome editing of the CFTR-locus for treatment of cystic fibrosisAmi M Kabadi, Leah Machlin, Nikita Dalal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleasesDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
Nature Methods|October 27, 2015
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsPratiksha I Thakore, Anthony M D'Ippolito, Lingyun Song, et al.
Pageof 2